In women with polycystic ovary syndrome, chromium picolinate (200 microg/d) improves glucose tolerance compared with placebo but does not improve ovulatory frequency or hormonal parameters. This pilot study indicates that future studies in the polycystic ovary syndrome population should examine higher dosages or longer durations of treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.fertnstert.2005.06.028 | DOI Listing |
Publication Analysis
Top Keywords
polycystic ovary
12
ovary syndrome
12
women polycystic
8
chromium supplementation
4
supplementation insulin
4
insulin resistance
4
resistance ovarian
4
ovarian menstrual
4
menstrual cyclicity
4
cyclicity women
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!